| 标题 |
543 VIDAR-1: a phase 1/2a master protocol for open-label, multi-centre, single-arm, first-in-human clinical studies of autologous TCR-T therapy targeting mutant KRAS in metastatic or locally advanced PDAC |
| 网址 | |
| DOI |
10.1136/jitc-2025-sitc2025.0543
doi
|
| 其它 |
期刊:Regular and Young Investigator Award Abstracts 作者:Hugh Salter; Zahid Bashir; Wolfgang Bethge; Michel Bitzer; Antonia Busse; et al 出版日期:2025-11-10 |
| 求助人 | |
| 下载 | 暂无链接,等待应助者上传 |
PDF的下载单位、IP信息已删除
(2025-6-4)